Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Shigehiro Tsujii"'
Autor:
Eri Munekage, Satoshi Serada, Shigehiro Tsujii, Keiichiro Yokota, Keita Kiuchi, Kenji Tominaga, Minoru Fujimoto, Mizuki Kanda, Sunao Uemura, Tsutomu Namikawa, Taisei Nomura, Ichiro Murakami, Kazuhiro Hanazaki, Tetsuji Naka
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 23, Iss 9, Pp 939-950 (2021)
An antibody-drug conjugate (ADC) is a promising therapeutic modality because selective and effective delivery of an anti-cancer drug is achieved by drug-conjugated antibody-targeting cancer antigen. Glypican 1 (GPC1) is highly expressed in malignant
Externí odkaz:
https://doaj.org/article/5785173f07364c98b9918dddf1a8cf79
Autor:
Tsutomu Namikawa, Keiichiro Yokota, Jun Iwabu, Masaya Munekage, Sunao Uemura, Shigehiro Tsujii, Hiromichi Maeda, Hiroyuki Kitagawa, Takashi Karashima, Masamitsu Kumon, Keiji Inoue, Michiya Kobayashi, Kazuhiro Hanazaki
Publikováno v:
JGH Open, Vol 4, Iss 5, Pp 903-908 (2020)
Abstract Background and Aim Disorders in bone metabolism have long been recognized as typical sequelae of gastrectomy; however, the pathogenesis has not been fully elucidated, resulting in a variation of reported incidence. This study aimed to evalua
Externí odkaz:
https://doaj.org/article/f20d54532eb4467fb0d609790a93880c
Autor:
Tsutomu Namikawa, Nobuko Ishida, Sachi Tsuda, Kazune Fujisawa, Eri Munekage, Jun Iwabu, Masaya Munekage, Sunao Uemura, Shigehiro Tsujii, Hiromichi Maeda, Hiroyuki Kitagawa, Michiya Kobayashi, Kazuhiro Hanazaki
Publikováno v:
Surgical Case Reports, Vol 4, Iss 1, Pp 1-5 (2018)
Abstract Background Although a recent randomized clinical trial has demonstrated that the objective response rate to nivolumab for metastatic gastric cancer was 11.2%, there was no patients confirmed complete response. Herein, we report on a case of
Externí odkaz:
https://doaj.org/article/61baac87b0eb473ab2649beacefbabca
Autor:
Tetsuji Naka, Kazuhiro Hanazaki, Yuichiro Doki, Hidetoshi Eguchi, Shogo Kobayashi, Ichiro Murakami, Tsutomu Namikawa, Sunao Uemura, Minoru Fujimoto, Takashi Matsunaga, Tsuyoshi Takahashi, Keisuke Toya, Shigehiro Tsujii, Satoshi Serada, Keiichiro Yokota
Supplementary Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfc6ce63e8850cb140e16ca4443bb29d
https://doi.org/10.1158/1535-7163.22522791
https://doi.org/10.1158/1535-7163.22522791
Autor:
Tetsuji Naka, Kazuhiro Hanazaki, Ichiro Murakami, Taisei Nomura, Tsutomu Namikawa, Sunao Uemura, Minoru Fujimoto, Satoshi Serada, Shigehiro Tsujii
Supplementary Table S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4442b584edbc3c9d2df696d81542f658
https://doi.org/10.1158/1535-7163.22522441.v1
https://doi.org/10.1158/1535-7163.22522441.v1
Autor:
Tetsuji Naka, Kazuhiro Hanazaki, Yuichiro Doki, Hidetoshi Eguchi, Shogo Kobayashi, Ichiro Murakami, Tsutomu Namikawa, Sunao Uemura, Minoru Fujimoto, Takashi Matsunaga, Tsuyoshi Takahashi, Keisuke Toya, Shigehiro Tsujii, Satoshi Serada, Keiichiro Yokota
Table S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91f5aa143508aa5e6694ba8d47ba07c9
https://doi.org/10.1158/1535-7163.22522785
https://doi.org/10.1158/1535-7163.22522785
Autor:
Tetsuji Naka, Kazuhiro Hanazaki, Ichiro Murakami, Taisei Nomura, Tsutomu Namikawa, Sunao Uemura, Minoru Fujimoto, Satoshi Serada, Shigehiro Tsujii
Pancreatic ductal adenocarcinoma (PDAC) is a stroma-rich cancer. Extracellular matrix proteins produced by cancer-associated fibroblasts (CAFs) found in tumor stroma that impedes effective delivery of chemotherapeutic agents results in poor response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cee6600586906d6c28b7e83f6e56654
https://doi.org/10.1158/1535-7163.c.6543376
https://doi.org/10.1158/1535-7163.c.6543376
Autor:
Tetsuji Naka, Kazuhiro Hanazaki, Ichiro Murakami, Taisei Nomura, Tsutomu Namikawa, Sunao Uemura, Minoru Fujimoto, Satoshi Serada, Shigehiro Tsujii
Supplementary Methods and Supplementary Fig. S1-S4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31b7d980e24cec7ac14a3a3f30bd11aa
https://doi.org/10.1158/1535-7163.22522444
https://doi.org/10.1158/1535-7163.22522444
Autor:
Tetsuji Naka, Kazuhiro Hanazaki, Yuichiro Doki, Hidetoshi Eguchi, Shogo Kobayashi, Ichiro Murakami, Tsutomu Namikawa, Sunao Uemura, Minoru Fujimoto, Takashi Matsunaga, Tsuyoshi Takahashi, Keisuke Toya, Shigehiro Tsujii, Satoshi Serada, Keiichiro Yokota
Figure S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9162ee9c313fd1d2a9e0f13d3adfa9fb
https://doi.org/10.1158/1535-7163.22522794
https://doi.org/10.1158/1535-7163.22522794
Autor:
Sunao Uemura, Minoru Fujimoto, Kazuhiro Hanazaki, Kenji Tominaga, Keita Kiuchi, Satoshi Serada, Tetsuji Naka, Taisei Nomura, Keiichiro Yokota, Shigehiro Tsujii, Ichiro Murakami, Mizuki Kanda, Eri Munekage, Tsutomu Namikawa
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 23, Iss 9, Pp 939-950 (2021)
Neoplasia (New York, N.Y.)
Neoplasia (New York, N.Y.)
Highlights • The authors developed a humanized anti-glypican-1 (GPC1) monoclonal antibody (clone T2) and produced an antibody-drug conjugate (ADC) linked to monomethyl auristatin E (MMAE). The ADC potently inhibited the growth of GPC1-positive panc